150 related articles for article (PubMed ID: 38427273)
1. Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG.
Liang F; Yin Z; Li Y; Li G; Ma J; Zhang H; Xia X; Yao M; Pang X; Wang J; Chang X; Guo J; Zhang W
Neurol Ther; 2024 Jun; 13(3):551-562. PubMed ID: 38427273
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis.
Zhao R; Wang Y; Huan X; Zhong H; Zhou Z; Xi J; Da Y; Lei L; Chang T; Ruan Z; Luo L; Li S; Yang H; Li Y; Luo S; Zhao C
J Transl Med; 2021 Jun; 19(1):285. PubMed ID: 34193193
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for the acute exacerbation of acetylcholine receptor antibody-positive generalized myasthenia gravis.
Chen J; Li S; Feng L; Wang H; Huang X; Feng H
Neurol Sci; 2023 Mar; 44(3):1049-1057. PubMed ID: 36369308
[TBL] [Abstract][Full Text] [Related]
4. Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma.
Supawongwattana M; Vanikieti K; Jindahra P; Padungkiatsagul T
Clin Ophthalmol; 2023; 17():649-656. PubMed ID: 36875532
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis.
Bi Z; Zhan J; Zhang Q; Gao H; Yang M; Ge H; Gui M; Lin J; Bu B
Front Immunol; 2023; 14():1177249. PubMed ID: 37266422
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
7. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
8. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
[TBL] [Abstract][Full Text] [Related]
9. The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.
Marcuse F; Brandts L; Moens D; Damoiseaux J; Hochstenbag M; Hoeijmakers JGJ; Maessen JG; De Baets M
Eur J Neurol; 2022 Apr; 29(4):1187-1197. PubMed ID: 34967067
[TBL] [Abstract][Full Text] [Related]
10. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
[TBL] [Abstract][Full Text] [Related]
11. Ravulizumab: A Review in Generalised Myasthenia Gravis.
Kang C
Drugs; 2023 Jun; 83(8):717-723. PubMed ID: 37166620
[TBL] [Abstract][Full Text] [Related]
12. Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.
van Steen C; Celico L; Spaepen E; Hagenacker T; Meuth SG; Ruck T; Smith AG; Bodicoat DH; de Francesco M; Iannazzo S
Adv Ther; 2024 Jun; 41(6):2486-2499. PubMed ID: 38642198
[TBL] [Abstract][Full Text] [Related]
13. An independently validated nomogram for individualised estimation of short-term mortality risk among patients with severe traumatic brain injury: a modelling analysis of the CENTER-TBI China Registry Study.
Lang L; Wang T; Xie L; Yang C; Skudder-Hill L; Jiang J; Gao G; Feng J
EClinicalMedicine; 2023 May; 59():101975. PubMed ID: 37180469
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis.
Ruan Z; Sun C; Lang Y; Gao F; Guo R; Xu Q; Yu L; Wu S; Lei T; Liu Y; Zhang M; Li H; Tang Y; Gao T; Gao Y; Lu X; Li Z; Chang T
Front Immunol; 2022; 13():895007. PubMed ID: 35874731
[TBL] [Abstract][Full Text] [Related]
15. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
Bi Z; Ge H; Zhang Q; Gao H; Yang M; Zhan J; Lin J; Gui M; Li Y; Ji S; Cao Y; Bu B
Pediatr Neurol; 2023 Sep; 146():31-39. PubMed ID: 37421800
[TBL] [Abstract][Full Text] [Related]
17. Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.
Kojima Y; Uzawa A; Ozawa Y; Yasuda M; Onishi Y; Akamine H; Kawaguchi N; Himuro K; Noto YI; Mizuno T; Kuwabara S
J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):963-968. PubMed ID: 33766920
[TBL] [Abstract][Full Text] [Related]
18. Predicting colorectal cancer risk: a novel approach using anemia and blood test markers.
Zhang Z; Zhang T; Zhang R; Zhu X; Wu X; Tan S; Jian Z
Front Oncol; 2024; 14():1347058. PubMed ID: 38344199
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Howard JF; Bril V; Vu T; Karam C; Peric S; De Bleecker JL; Murai H; Meisel A; Beydoun SR; Pasnoor M; Guglietta A; Van Hoorick B; Steeland S; T'joen C; Utsugisawa K; Verschuuren J; Mantegazza R;
Front Neurol; 2023; 14():1284444. PubMed ID: 38318236
[TBL] [Abstract][Full Text] [Related]
20. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
